Analyst rating
Based on 2 analysts giving stock ratings to VTGN in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
In the next quarter Vistagen Therapeutics, Inc. revenue is expected to reach 647.00 K USD. Check out Vistagen Therapeutics, Inc. revenue and earnings and make informed decisions.